Login / Register
Menu
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
Search
×
Cancer Tissue Gallery AGR2
Path
Created with Sketch.
Go to AGR2 Normal Tissue Gallery
Go back to Product Page
Adrenal gland – AGR2 negative adrenocortical adenoma
Adrenal gland – AGR2 negative adrenocortical adenoma
Anal canal – Squamous cell carcinoma with variable, weak to strong AGR2 staining of tumor cells
Anal canal – Squamous cell carcinoma with variable, weak to strong AGR2 staining of tumor cells
Breast – Invasive breast cancer of no special type (NST) displaying a strong AGR2 staining of 100_ of tumor cells
Breast – Invasive breast cancer of no special type (NST) displaying a strong AGR2 staining of 100_ of tumor cells
Breast – Invasive lobular breast cancer with strong AGR2 positivity of tumor cells
Breast – Invasive lobular breast cancer with strong AGR2 positivity of tumor cells
Colon – Colorectal adenocarcinoma with intense AGR2 staining of tumor cells
Colon – Colorectal adenocarcinoma with intense AGR2 staining of tumor cells
Esophagus – Adenocarcinoma with strong AGR2 positivity of tumor cells
Esophagus – Adenocarcinoma with strong AGR2 positivity of tumor cells
Esophagus – AGR2 negative squamous cell carcinoma
Esophagus – AGR2 negative squamous cell carcinoma
Kidney – AGR2 negative chromophobe renal cell carcinoma
Kidney – AGR2 negative chromophobe renal cell carcinoma
Kidney – AGR2 negative papillary renal cell carcinoma
Kidney – AGR2 negative papillary renal cell carcinoma
Liver – AGR2 negative hepatocellular carcinoma
Liver – AGR2 negative hepatocellular carcinoma
Liver – Cholangiocellular carcinoma with strong AGR2 immunostaining of tumor cells
Liver – Cholangiocellular carcinoma with strong AGR2 immunostaining of tumor cells
Lung – Adenocarcinoma with strong AGR2 positivty of all tumor cells
Lung – Adenocarcinoma with strong AGR2 positivty of all tumor cells
Lymph node – AGR2 negative Hodgkin’s lymphoma
Lymph node – AGR2 negative Hodgkin’s lymphoma
Ovary – Endometroid carcinoma with strong AGR2 positivity of tumor cells
Ovary – Endometroid carcinoma with strong AGR2 positivity of tumor cells
Ovary – Serous high-grade carcinoma with weak to moderate AGR2 staining of only few tumor cells
Ovary – Serous high-grade carcinoma with weak to moderate AGR2 staining of only few tumor cells
Pancreas – AGR2 negative neuroendocrine tumor
Pancreas – AGR2 negative neuroendocrine tumor
Pancreas – Ductal adenocarcinoma with strong AGR2 positivity of all tumor cells
Pancreas – Ductal adenocarcinoma with strong AGR2 positivity of all tumor cells
Penis – AGR2 negative squamous cell carcinoma
Penis – AGR2 negative squamous cell carcinoma
Prostate – Adenocarcinoma (Gleason 3+3=6) with strong AGR2 staining of all tumor cells
Prostate – Adenocarcinoma (Gleason 3+3=6) with strong AGR2 staining of all tumor cells
Prostate – AGR2 negative adenocarcinoma (Gleason 5+5=10)
Prostate – AGR2 negative adenocarcinoma (Gleason 5+5=10)
Salivary gland – Warthin tumor with strong AGR2 positivity of most tumor cells
Salivary gland – Warthin tumor with strong AGR2 positivity of most tumor cells
Skin – AGR2 negative malignant melanoma
Skin – AGR2 negative malignant melanoma
Soft tissue – AGR2 negative leiomyosarcoma
Soft tissue – AGR2 negative leiomyosarcoma
Stomach – AGR2 negative gastrointestinal stromal tumor (GIST)
Stomach – AGR2 negative gastrointestinal stromal tumor (GIST)
Stomach – Gastric adenocarcinoma (diffuse type) with strong AGR2 staining of all tumor cells
Stomach – Gastric adenocarcinoma (diffuse type) with strong AGR2 staining of all tumor cells
Stomach – Gastric adenocarcinoma (intestinal type) exhibiting a strong AGR2 positivity of all tumor cells
Stomach – Gastric adenocarcinoma (intestinal type) exhibiting a strong AGR2 positivity of all tumor cells
Testis – AGR2 negative embryonal carcinoma
Testis – AGR2 negative embryonal carcinoma
Testis – AGR2 negative Leydig cell tumor
Testis – AGR2 negative Leydig cell tumor
Testis – AGR2 negative seminoma
Testis – AGR2 negative seminoma
Thyroid – AGR2 negative follicular carcinoma
Thyroid – AGR2 negative follicular carcinoma
Thyroid – Medullary cancer with strong AGR2 staining of all tumor cells
Thyroid – Medullary cancer with strong AGR2 staining of all tumor cells
Thyroid – Papillary cancer with distinct AGR2 staining of a small subset of tumor cells
Thyroid – Papillary cancer with distinct AGR2 staining of a small subset of tumor cells
Thyroid – Papillary cancer with strong AGR2 positivity of tumor cells
Thyroid – Papillary cancer with strong AGR2 positivity of tumor cells
Urinary bladder – AGR2 negative muscle-invasive urothelial carcinoma
Urinary bladder – AGR2 negative muscle-invasive urothelial carcinoma
Urinary bladder – Muscle-invasive urothelial carcinoma with strong AGR2 staining of all tumor cells
Urinary bladder – Muscle-invasive urothelial carcinoma with strong AGR2 staining of all tumor cells
Urinary bladder – Non-invasive urothelial carcinoma (low grade, pTaG2) with strong AGR2 positivity of tumor cells
Urinary bladder – Non-invasive urothelial carcinoma (low grade, pTaG2) with strong AGR2 positivity of tumor cells
Uterus, cervix – Adenocarcinoma showing an intense AGR2 immunostaining of tumor cells
Uterus, cervix – Adenocarcinoma showing an intense AGR2 immunostaining of tumor cells
Uterus, cervix – Squamous cell carcinoma with strong AGR2 staining of tumor cells
Uterus, cervix – Squamous cell carcinoma with strong AGR2 staining of tumor cells